Product How it works Pricing Blog FAQ About Contact
RD Saúde

RD Saúde (B3: RADL3) net income

RD Saúde reported a net profit of BRL 1,297m for fiscal 2025, 8.1% more than in fiscal 2024 (BRL 1,200m). Its net margin was 2.9%.

Net income, in millions of Brazilian reais447.72016511.22017502.42018772.22019484.42020751.92021996.120221,05520231,20020241,2972025

Net income by fiscal year

Fiscal yearNet incomeChangeNet margin
2025BRL 1,297m+8.1%2.9%
2024BRL 1,200m+13.7%3.1%
2023BRL 1,055m+5.9%3.1%
2022BRL 996.1m+32.5%3.4%
2021BRL 751.9m+55.2%3.1%
2020BRL 484.4m−37.3%2.4%
2019BRL 772.2m+53.7%4.4%
2018BRL 502.4m−1.7%3.4%
2017BRL 511.2m+14.2%3.9%
2016BRL 447.7m—4.0%

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of Brazilian reais, except per-share amounts.

Questions about the net income of RD Saúde

How much did RD Saúde earn in fiscal 2025?
RD Saúde reported a net profit of BRL 1,297m for fiscal 2025. In fiscal 2024 it reported a net profit of BRL 1,200m.
What is the net margin of RD Saúde?
In fiscal 2025 its net profit was 2.9% of its revenue.
What was the most profitable year for RD Saúde?
Of its last 10 fiscal years, fiscal 2025, with BRL 1,297m.
Where do the figures for RD Saúde come from?
From the annual financial statements (DFP) that RD Saúde files with the CVM, the Brazilian securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual financial statements (DFP) that RD Saúde files with the CVM, the Brazilian securities regulator. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on RD Saúde: the RD Saúde page · annual accounts · revenue · dividends paid.

More companies from Brazil and the rest of the region: Latin American stocks.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.